GSK Pakistan Appoints Dmytro Oliinyk as Chairperson -

CORPORATE WORLD

GlaxoSmithKline Pakistan Limited has announced the appointment of Dmytro Oliinyk as Non-Executive Director and Chairperson of the Board, effective April 2026.

According to a formal notification issued to the Pakistan Stock Exchange, the appointment has been made to fill a casual vacancy arising from the resignation of a board member. The decision was taken by the company’s Board of Directors.

Mr. Oliinyk currently serves as Vice President and Head of Finance for the International Region at GlaxoSmithKline. With extensive experience in financial leadership and international operations, his appointment is expected to strengthen corporate governance and strategic direction at GSK Pakistan.

The company has requested the Exchange to inform TRE Certificate Holders accordingly.

GlaxoSmithKline Pakistan Limited is a leading pharmaceutical and healthcare company operating in Pakistan. It is a subsidiary of the global healthcare giant GlaxoSmithKline, headquartered in the United Kingdom.

The company is engaged in the manufacturing, marketing, and distribution of a wide range of prescription medicines, vaccines, and consumer healthcare products. With a longstanding presence in Pakistan, GSK has played a significant role in improving public health through innovative treatments and healthcare solutions.

GSK Pakistan is listed on the Pakistan Stock Exchange and maintains a strong footprint in both the pharmaceutical and consumer health sectors. – ER News Desk

READ MORE